Targeting vascular calcification: softening-up a hard target.

Area of Science:

• Cardiovascular Medicine
• Vascular Biology
• Biochemistry

Background:

• Vascular calcification is a common feature of aging and associated with pathologies like atherosclerosis, renal failure, and diabetes.
• Previously considered benign, vascular calcification is now recognized as a causal factor in vascular events and chronic cardiovascular damage.
• Significant research has elucidated factors promoting calcification and its underlying mechanisms.

Purpose of the Study:

• To review the current understanding of vascular calcification formation and progression.
• To identify potential therapeutic targets for blocking or regressing vascular calcification.
• To highlight challenges in targeting vascular calcification and the need for careful evaluation of treatments.

Main Methods:

• Literature review of studies on vascular calcification.
• Analysis of factors influencing calcification in vivo.
• Examination of mechanisms initiating and promoting vascular calcification.
• Identification of potential therapeutic targets, including calcification inhibitors and factors affecting vascular smooth muscle cell apoptosis.

Main Results:

• Emerging evidence indicates vascular calcification is a causal factor in cardiovascular events.
• Novel targets for intervention, including inhibitors and modulators of vascular smooth muscle cell apoptosis, have been identified.
• Effective treatments for vascular calcification are currently lacking, and the vasculature is a challenging tissue to target.

Conclusions:

• Vascular calcification is an active pathological process with potential therapeutic targets.
• Future treatments must consider potential impacts on bone metabolism.
• Normalizing aberrant mineral metabolism in conditions like renal failure may be a key strategy to manage accelerated vascular calcification.